← Evidence map

ReviewClinical lymphoma, myeloma & leukemia2021

Programmed Cell Death-One Inhibition Therapy in Classical Hodgkin Lymphoma.

Samer A Al-Hadidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33160934